CuraCell TX AB
European biotech developing personalized T-cell therapies for solid cancer tumors.
Översikt
- 5
- Anställda
- 45t SEK
- Omsättning
- 2020
- Grundat
Nyckelbeslutsfattare
Håkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Jonas Båtelson
CEO
+3 fler kontakter i Funnelfeedr
Beskrivning
CuraCell is a European biotech company focused on developing innovative T-cell therapies for the treatment of solid cancer tumors. The company utilizes its proprietary platform, CytoPLY, designed to significantly expand and activate the patient's own tumor-reactive T-cells. Their primary therapeutic...